2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine

C106H124F2N26O6 — CID 162026903

About 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine

2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine (PubChem CID 162026903) has the molecular formula C106H124F2N26O6 and a molecular weight of 1896.33 g/mol. Its IUPAC name is 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine.

Molecular Properties

• Compound Name: 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine
• PubChem CID: 162026903
• Molecular Formula: C106H124F2N26O6
• Molecular Weight: 1896.33 g/mol
• Exact Mass: 1895.02
• IUPAC Name: 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine
• SMILES: CC1(C)CC(Oc2ccc(-c3cc(F)c(-c4cn[nH]c4)cc3F)nn2)CC(C)(C)N1.CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3)nn2)CC(C)(C)N1.COc1cc(-c2cn[nH]c2)ccc1-c1ccc(N(C)C2CC(C)(C)NC(C)(C)C2)nn1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(C2C[C@H]3CC[C@@H](C2)N3)nn1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(OC2CCNCC2)nn1
• InChI: InChI=1S/C24H32N6O.C22H25F2N5O.C22H27N5O.C20H21N5O.C18H19N5O2/c1-23(2)12-18(13-24(3,4)29-23)30(5)22-10-9-20(27-28-22)19-8-7-16(11-21(19)31-6)17-14-25-26-15-17;1-21(2)9-14(10-22(3,4)29-21)30-20-6-5-19(27-28-20)16-8-17(23)15(7-18(16)24)13-11-25-26-12-13;1-21(2)11-18(12-22(3,4)27-21)28-20-10-9-19(25-26-20)16-7-5-15(6-8-16)17-13-23-24-14-17;26-20-9-12(14-10-21-22-11-14)1-4-17(20)19-6-5-18(24-25-19)13-7-15-2-3-16(8-13)23-15;24-17-9-12(13-10-20-21-11-13)1-2-15(17)16-3-4-18(23-22-16)25-14-5-7-19-8-6-14/h7-11,14-15,18,29H,12-13H2,1-6H3,(H,25,26);5-8,11-12,14,29H,9-10H2,1-4H3,(H,25,26);5-10,13-14,18,27H,11-12H2,1-4H3,(H,23,24);1,4-6,9-11,13,15-16,23,26H,2-3,7-8H2,(H,21,22);1-4,9-11,14,19,24H,5-8H2,(H,20,21)/t;;;13?,15-,16+
• InChIKey: YVMRZDABSMUHNV-GIXWSYTDSA-N
• XLogP: 18.62
• TPSA: 413.07 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 27
• Rotatable Bonds: 20
• Heavy Atoms: 140
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1896.33
LogP ≤ 5	18.62
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	27

Frequently Asked Questions

What is the IUPAC name of 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?

The IUPAC name of 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine (CID 162026903) is 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine.

What is the SMILES notation for 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?

The canonical SMILES for 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine is CC1(C)CC(Oc2ccc(-c3cc(F)c(-c4cn[nH]c4)cc3F)nn2)CC(C)(C)N1.CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3)nn2)CC(C)(C)N1.COc1cc(-c2cn[nH]c2)ccc1-c1ccc(N(C)C2CC(C)(C)NC(C)(C)C2)nn1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(C2C[C@H]3CC[C@@H](C2)N3)nn1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(OC2CCNCC2)nn1.

What is the InChIKey of 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?

The InChIKey is YVMRZDABSMUHNV-GIXWSYTDSA-N. The full InChI is InChI=1S/C24H32N6O.C22H25F2N5O.C22H27N5O.C20H21N5O.C18H19N5O2/c1-23(2)12-18(13-24(3,4)29-23)30(5)22-10-9-20(27-28-22)19-8-7-16(11-21(19)31-6)17-14-25-26-15-17;1-21(2)9-14(10-22(3,4)29-21)30-20-6-5-19(27-28-20)16-8-17(23)15(7-18(16)24)13-11-25-26-12-13;1-21(2)11-18(12-22(3,4)27-21)28-20-10-9-19(25-26-20)16-7-5-15(6-8-16)17-13-23-24-14-17;26-20-9-12(14-10-21-22-11-14)1-4-17(20)19-6-5-18(24-25-19)13-7-15-2-3-16(8-13)23-15;24-17-9-12(13-10-20-21-11-13)1-2-15(17)16-3-4-18(23-22-16)25-14-5-7-19-8-6-14/h7-11,14-15,18,29H,12-13H2,1-6H3,(H,25,26);5-8,11-12,14,29H,9-10H2,1-4H3,(H,25,26);5-10,13-14,18,27H,11-12H2,1-4H3,(H,23,24);1,4-6,9-11,13,15-16,23,26H,2-3,7-8H2,(H,21,22);1-4,9-11,14,19,24H,5-8H2,(H,20,21)/t;;;13?,15-,16+;.

What are the key properties of 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?

2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine has a molecular weight of 1896.33 g/mol, XLogP of 18.62, 20 rotatable bonds, 12 hydrogen bond donors, and 27 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[6-[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[2,5-difluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;6-[2-methoxy-4-(1H-pyrazol-4-yl)phenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;2-(6-piperidin-4-yloxypyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol;3-[4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine is sourced from PubChem (CID 162026903), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).